Targeting the MAP kinase pathway in astrocytoma cells using a recombinant anthrax lethal toxin as a way to inhibit cell motility and invasion
- 9 March 2016
- journal article
- Published by Spandidos Publications in International Journal of Oncology
- Vol. 48 (5) , 1913-1920
Abstract
Spandidos Publications is a scientific publisher with a long-standing international reputation for excellent standards and high quality science publicationsKeywords
This publication has 37 references indexed in Scilit:
- The regulation of RhoA at focal adhesions by StarD13 is important for astrocytoma cell motilityExperimental Cell Research, 2014
- RhoA, RhoB and RhoC have different roles in cancer cell migrationJournal of Microscopy, 2013
- RhoA and RhoC have distinct roles in migration and invasion by acting through different targetsJournal of Cell Biology, 2011
- Systemic Anthrax Lethal Toxin Therapy Produces Regressions of Subcutaneous Human Melanoma Tumors in Athymic Nude MiceClinical Cancer Research, 2006
- Regulation of cancer cell motility through actin reorganizationCancer Science, 2005
- Rho GTPase-activating proteins in cell regulationTrends in Cell Biology, 2003
- The role of Rho GTPases in disease developmentGene, 2002
- Proteolytic Inactivation of MAP-Kinase-Kinase by Anthrax Lethal FactorScience, 1998
- A synthetic inhibitor of the mitogen-activated protein kinase cascade.Proceedings of the National Academy of Sciences, 1995
- Subsets of Glioblastoma Multiforme Defined by Molecular Genetic AnalysisBrain Pathology, 1993